Early Increased Bradykinin 1 Receptor Contributes to Hemorrhagic Transformation After Ischemic Stroke in Type 1 Diabetic Rats

[1]  Gelin Xu,et al.  Tissue Kallikrein Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the B2R-ERK1/2-CREB-Bcl-2 Signaling Pathway in Diabetic Rats , 2016, Oxidative medicine and cellular longevity.

[2]  H. Zhang,et al.  Opposite roles of bradykinin B1 and B2 receptors during cerebral ischaemia–reperfusion injury in experimental diabetic rats , 2016, The European journal of neuroscience.

[3]  S. Lai,et al.  Matrix metalloproteinase-9 leads to blood-brain barrier leakage in mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis. , 2014, Acta tropica.

[4]  N. Blaes,et al.  Kinin receptors in vascular biology and pathology. , 2014, Current vascular pharmacology.

[5]  F. Sharp,et al.  Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  U. Kishore,et al.  Soluble gC1qR Is an Autocrine Signal That Induces B1R Expression on Endothelial Cells , 2014, The Journal of Immunology.

[7]  M. Lou,et al.  Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats , 2013, Neuroscience.

[8]  M. Marre,et al.  Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[9]  D. Liebeskind,et al.  Recommendations for Preclinical Research in Hemorrhagic Transformation , 2013, Translational Stroke Research.

[10]  Mahlon D. Johnson,et al.  Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease , 2013, Brain pathology.

[11]  E. Lo,et al.  Neurovascular matrix metalloproteinases and the blood-brain barrier. , 2012, Current pharmaceutical design.

[12]  Michael Bader,et al.  Altered Glucose Homeostasis and Hepatic Function in Obese Mice Deficient for Both Kinin Receptor Genes , 2012, PloS one.

[13]  G. Plante,et al.  Impact of kinins in the treatment of cardiovascular diseases. , 2012, Pharmacology & therapeutics.

[14]  V. Nerurkar,et al.  West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. , 2012, The Journal of general virology.

[15]  M. Lepage,et al.  Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model , 2012, PloS one.

[16]  QinHu,et al.  Isoflurane Enhanced Hemorrhagic Transformation by Impairing Antioxidant Enzymes in Hyperglycemic Rats With Middle Cerebral Artery Occlusion , 2011 .

[17]  N. Plesnila,et al.  Contribution of Bradykinin Receptors to the Development of Secondary Brain Damage After Experimental Subarachnoid Hemorrhage , 2011, Neurosurgery.

[18]  John H. Zhang,et al.  Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model , 2010, Neuroscience.

[19]  T. Renné,et al.  Inhibition of Bradykinin Receptor B1 Protects Mice from Focal Brain Injury by Reducing Blood–Brain Barrier Leakage and Inflammation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  K. Bhoola,et al.  Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease‐9 and myeloperoxidase in human neutrophils: involvement of mitogen‐activated protein kinase family , 2009, Journal of leukocyte biology.

[21]  Q. Dong,et al.  Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition. , 2009, Biochemical and biophysical research communications.

[22]  W. Ageno,et al.  Acute Hyperglycemia and Early Hemorrhagic Transformation in Ischemic Stroke , 2009, Cerebrovascular Diseases.

[23]  T. Walther,et al.  Gene Deletion of the Kinin Receptor B1 Attenuates Cardiac Inflammation and Fibrosis During the Development of Experimental Diabetic Cardiomyopathy , 2009, Diabetes.

[24]  T. Renné,et al.  Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema , 2009, Stroke.

[25]  Giancarlo Comi,et al.  Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome: Results of a Prospective Multicenter Study , 2008, Stroke.

[26]  G. Steinberg,et al.  Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke , 2008, Journal of neuroscience research.

[27]  M. Mori,et al.  Kinin B1 Receptor Deficiency Leads to Leptin Hypersensitivity and Resistance to Obesity , 2008, Diabetes.

[28]  S. Talbot,et al.  Retinal plasma extravasation in streptozotocin‐diabetic rats mediated by kinin B1 and B2 receptors , 2008, British journal of pharmacology.

[29]  E. Lo,et al.  MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke , 2008, Stroke.

[30]  Sumit R. Majumdar,et al.  Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis , 2008, Diabetes Care.

[31]  C. Libert,et al.  Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation , 2007, Journal of leukocyte biology.

[32]  I. Komuro,et al.  Bradykinin-Induced Microglial Migration Mediated by B1-Bradykinin Receptors Depends on Ca2+ Influx via Reverse-Mode Activity of the Na+/Ca2+ Exchanger , 2007, The Journal of Neuroscience.

[33]  P. Chan,et al.  Influence of Hyperglycemia on Oxidative Stress and Matrix Metalloproteinase-9 Activation After Focal Cerebral Ischemia/Reperfusion in Rats: Relation to Blood-Brain Barrier Dysfunction , 2007, Stroke.

[34]  R. Iliescu,et al.  Mice deficient for both kinin receptors are normotensive and protected from endotoxin‐induced hypotension , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  M. Mori,et al.  Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function , 2006, Biological chemistry.

[36]  M. Gassmann,et al.  Brain‐derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK‐1/‐2 and Akt pathways , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  H. Gavras,et al.  Age-related changes of bradykinin B1 and B2 receptors in rat heart. , 2005, American journal of physiology. Heart and circulatory physiology.

[38]  Cheorl-Ho Kim,et al.  ERK1/2 mediates TNF‐α‐induced matrix metalloproteinase‐9 expression in human vascular smooth muscle cells via the regulation of NF‐κB and AP‐1: Involvement of the ras dependent pathway , 2004, Journal of cellular physiology.

[39]  Guo-Yuan Yang,et al.  Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia , 2004, Brain Research.

[40]  K. Arai,et al.  Essential role for ERK mitogen‐activated protein kinase in matrix metalloproteinase‐9 regulation in rat cortical astrocytes , 2003, Glia.

[41]  K. Csiszȧr,et al.  Diabetes activates cell death pathway after transient focal cerebral ischemia. , 2003, Diabetes.

[42]  T. Sugawara,et al.  Copper/Zinc Superoxide Dismutase Attenuates Neuronal Cell Death by Preventing Extracellular Signal-Regulated Kinase Activation after Transient Focal Cerebral Ischemia in Mice , 2002, The Journal of Neuroscience.

[43]  J. Broderick,et al.  Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial , 2002, Neurology.

[44]  J. Schanstra,et al.  Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. , 2002, Canadian journal of physiology and pharmacology.

[45]  K. Frei,et al.  Molecular and cellular permeability control at the blood–brain barrier , 2001, Brain Research Reviews.

[46]  M. Chopp,et al.  Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.

[47]  Erich Bluhmki,et al.  Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II) , 2001, Stroke.

[48]  D. Holtzman,et al.  BDNF Protects the Neonatal Brain from Hypoxic-Ischemic InjuryIn Vivo via the ERK Pathway , 2000, The Journal of Neuroscience.

[49]  B. Morris,et al.  Kainate receptors activate NF‐κB via MAP kinase in striatal neurones , 2000, Neuroreport.

[50]  J. Calixto,et al.  In vivo B1 kinin‐receptor upregulation. Evidence for involvement of protein kinases and nuclear factor κB pathways , 1999, British journal of pharmacology.

[51]  L. Chao,et al.  The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats , 1999, British journal of pharmacology.

[52]  J. Schanstra,et al.  The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. , 1998, The Journal of clinical investigation.

[53]  R. Busto,et al.  Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats , 1996, Brain Research.

[54]  S. Cruwys,et al.  The role of bradykinin B1 receptors in the maintenance of intra‐articular plasma extravasation in chronic antigen‐induced arthritis , 1994, British journal of pharmacology.

[55]  M. Balda,et al.  Tight junctions: molecular architecture and function. , 2006, International Review of Cytology.

[56]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.